Fund manager · Mirae

Sudip Shere

ETF Dealer at Mirae. Runs 24 schemes worth ₹1,007 Cr.

Fund house
MiraeThey run their schemes at Mirae.
AUM they run
₹1,007 CrThe AUM of the schemes they run, as main or co-manager, at the latest month's end, as AMFI reports it. A scheme two people run counts for both.
Schemes
24 now · 0 beforeSchemes they run now, as main or co-manager, and ones they ran before, since Oct 2026.
Experience
9 yearsMr. Sudip Shere has over 9 years of experience in the field of financial services. He has been associated with the AMC since

What Sudip Shere's schemes hold^{(Feb 2026 – Sept 2026)}

What Sudip Shere's schemes hold in Sept 2026. Tick up to 2 to plot them.
Plot	44 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	1.6
	Divi s Laboratories Limited	1.4
	Apollo Hospitals Enterprise Limited	0.96
	Laurus Labs Limited	0.88
	Cipla	0.86
	Dr Reddy s Laboratories Limited	0.86
	Torrent Pharmaceuticals Limited	0.8
	Max Healthcare Institute Limited	0.79
	Lupin	0.56
	Aurobindo Pharma	0.53
	Fortis Healthcare Limited	0.46
	Glenmark Pharmaceuticals	0.4
	Alkem Laboratories Limited	0.35
	Cadila Healthcare	0.33
	Mankind Pharma Limited	0.32
	IPCA Laboratories Limited	0.3
	Biocon	0.29
	Gland Pharma Limited	0.26
	Sai Life Sciences Limited	0.24
	Krishna Institute of Medical Science Ltd	0.23
	Aster DM Healthcare Limited	0.21
	Neuland Laboratories Limited	0.21
	Wockhardt	0.2
	Acutaas Chemicals Limited	0.19
	Ajanta Pharmaceuticals Limited	0.19
	Dr Lal Path Labs Limited	0.18
	Abbott India Limited	0.16
	Piramal Pharma Limited	0.15
	Granules India Limited	0.14
	Narayana Hrudayalaya Limited	0.14
	Global Health Limited	0.14
	Onesource Speciality Pharma Ltd	0.14
	GLAXO SMITHKLINE PHARMA	0.13
	Anthem Biosciences Limited	0.11
	Emcure Pharmaceuticals Limited	0.09
	Natco Pharma	0.08
	Cohance Lifesciences Limited	0.08
	Vijaya Diagnostic Centre Limited	0.08
	Syngene International Limited	0.08
	Rainbow Children s Medicare Limited	0.07
	Poly Medicure Limited	0.07
	Rubicon Research Limited	0.07
	Caplin Point Laboratories Limited	0.06
	Concord Biotech Limited	0.05

Sun Pharmaceutical Ind Ltd
Divi s Laboratories Limited

Market value of each ticked company across the schemes Sudip Shere runs, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Divi s Laboratories Limited
Sept 2025	₹0 Cr	₹0 Cr
Oct 2025	₹0 Cr	₹0 Cr
Nov 2025	₹0 Cr	₹0 Cr
Dec 2025	₹0 Cr	₹0 Cr
Jan 2026	₹0 Cr	₹0 Cr
Feb 2026	₹0.73 Cr	₹0.5 Cr
Mar 2026	₹0.76 Cr	₹0.51 Cr
Apr 2026	₹0.9 Cr	₹0.63 Cr
May 2026	₹1.1 Cr	₹0.81 Cr
Jun 2026	₹1.3 Cr	₹0.84 Cr
Jul 2026	₹1.4 Cr	₹1 Cr
Aug 2026	₹1.5 Cr	₹1.3 Cr
Sept 2026	₹1.6 Cr	₹1.4 Cr

Fig. 1.Market value of each ticked company across the schemes Sudip Shere runs, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of AUM
Large Cap	5	35.98

Mid Cap	18	45.64

Small Cap	21	18.34

Sectors

Companies

Fig. 2.What the schemes this manager runs hold, all together, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

What Sudip Shere bought and sold^{(Feb 2026 – Sept 2026)}

What Sudip Shere bought and sold. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.